Boehringer Ingelheim

Boehringer Ingelheim India has shared its roadmap of partnerships and patient access programmes to sustain its growth momentum in…

Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers

She was formerly the Global Head of Boehringer Ingelheim’s Go-To-Market and Business Steering organisation, based in the company’s…

It is the generic version of Pradaxa Capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim 

Transaction expands Boehringer Ingelheim’s R&D and clinical manufacturing capabilities with a site focused predominantly on…

The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline…

Under the License Agreement, Bridge Biotherapeutics will regain all rights to BBT-877

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…

Under the terms of the partnership agreement, Click Therapeutics will be primarily responsible for research and development…